A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates

Due to compromised immune system, fungal infection incidences have markedly increased in the last few decades. Pathogenic fungi have developed resistance to the clinically available antifungal agents. Antifungal resistance poses a great challenge to clinical treatment and has stimulated the demand f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Wang, Chenxi, Gao, Nan, Lyu, Yinfeng, Zhang, Licong, Zhang, Sujiang, Wang, Jiajun, Shan, Anshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554340/
https://www.ncbi.nlm.nih.gov/pubmed/33101226
http://dx.doi.org/10.3389/fmicb.2020.548620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554340/
https://www.ncbi.nlm.nih.gov/pubmed/33101226
http://dx.doi.org/10.3389/fmicb.2020.548620

Ejemplares similares